Table 2 Associations between NLR and clinicopathologic characteristics
Variables | NLR < 2.39 (n = 78) | NLR ≥ 2.39 (n = 44) | P value |
|---|---|---|---|
Age/years | 0.451 | ||
< 60 | 37 (47.4%) | 24 (54.5%) | |
≥ 60 | 41 (52.6%) | 20 (45.5%) | |
Gender | 0.596 | ||
Male | 55 (70.5%) | 33 (75%) | |
Female | 23 (29.5%) | 11 (25%) | |
BMI | 0.187 | ||
≥ 25 | 38 (48.7%) | 16 (36.4%) | |
< 25 | 40 (51.3%) | 28 (63.6%) | |
Diabetes/hyperglycemia, n (%) | 0.363 | ||
No | 67 (85.9%) | 35 (79.5%) | |
Yes | 11 (14.1%) | 9 (250.5%) | |
TNM stage (AJCC 8th) | 0.001a | ||
I | 71 (91%) | 30 (68.2%) | |
II | 4 (5.1%) | 6 (13.5%) | |
III | 3 (3.9%) | 5 (11.5%) | |
IV | 0 | 3 (6.8%) | |
Surgical type | 0.063 | ||
RN | 36 (46.2%) | 28 (63.6%) | |
PN | 42 (53.8%) | 16 (36.4%) | |
Tumor size (cm) | 0.011 | ||
< 7 | 68 (87.2%) | 30 (68.2%) | |
≥ 7 | 10 (12.8%) | 14 (31.8%) | |
Subtype, n (%) | 0.022 | ||
I | 47 (60.3%) | 17 (38.6%) | |
II | 31 (39.7%) | 27 (61.4%) | |
Serum album (g/l) | 0.925 | ||
≥ 40 | 45 (57.7%) | 25 (56.8%) | |
< 40 | 33 (42.3%) | 19 (43.2%) | |
CHOL | 0.085 | ||
< 4.90 | 37 (47.4%) | 28 (63.6%) | |
≥ 4.90 | 41 (52.6%) | 16 (36.4%) | |
BUN/Cr | 0.274 | ||
< 20 | 53 (67.9%) | 34 (77.3%) | |
≥ 20 | 25 (32.1%) | 10 (22.7%) |